Arrythmia
Conditions
Keywords
Patient engagement
Brief summary
In this patient engagement study, patients and partners will attend a presentation, group meeting and responding to the survey to help the research team gage the acceptability of using a biological therapy to prevent cardiac arrhythmia. Patient Partners will also help to clarify which outcomes are important to patients, to ensure the selected outcomes align with patient interests.
Detailed description
There will be four study groups: 1. Heart patients who experienced a cardiac arrhythmia while in hospital, 2. Heart patients who did not experience a cardiac arrhythmia while in hospital, 3. Heart patients with an upcoming procedure that have not had a cardiac arrhythmia, 4. Members of the general public. There will be a presentation, two surveys and a team meeting. Results will be compiled and analyzed.
Interventions
OTHERSurveys
Surveys to evaluate prior experience, opinions and intervention acceptability.
OTHERFocus group
To answer any questions and discuss topics covered in the standard presentation.
Sponsors
Ottawa Heart Institute Research Corporation
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Upcoming or previous cardiac procedure.
Exclusion criteria
* Inability to complete an electronic survey or participate in a small group meeting.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants that would accept a biological therapy for a cardiac arrhythmia as assessed using a survey | 2 years | accept a biological therapy |
Countries
Canada
Outcome results
None listed